These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1168 related articles for article (PubMed ID: 7871571)

  • 21. The contribution of terminal complement components to acute and hyperacute allograft rejection in the rat.
    Brauer RB; Baldwin WM; Ibrahim S; Sanfilippo F
    Transplantation; 1995 Jan; 59(2):288-93. PubMed ID: 7839453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intrathymic alloantigen-mediated, tolerant, completely major histocompatibility complex-mismatched mouse hearts are specifically rejected by adoptively transferred anti-class I L(d+)-specific 2C cells.
    Otomo N; Motoyama K; Yu S; Shimizu Y; Margenthaler J; Tu F; Flye MW
    Surgery; 2000 Aug; 128(2):206-12. PubMed ID: 10922993
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune mechanisms in organ allograft rejection. III. Cellular and humoral immunity in rejection of organ allografts transplanted across MHC subregion disparity RT1.B (RT1.D).
    Lowry RP; Gurley KE
    Transplantation; 1983 Oct; 36(4):405-11. PubMed ID: 6353708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adoptively transferred CD4+ lymphocytes from CD8 -/- mice are sufficient to mediate the rejection of MHC class II or class I disparate skin grafts.
    Dalloul AH; Chmouzis E; Ngo K; Fung-Leung WP
    J Immunol; 1996 Jun; 156(11):4114-9. PubMed ID: 8666777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The rejection mechanism of rat pancreaticoduodenal allografts with a class I MHC disparity.
    Yamamoto S; Ito T; Nakata S; Nozaki S; Uchikoshi F; Shirakura R; Kamiike W; Miyata M; Matsuda H
    Transplantation; 1994 Apr; 57(8):1217-22. PubMed ID: 7909966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Limited T cell response to donor MHC peptides during allograft rejection. Implications for selective immune therapy in transplantation.
    Benichou G; Fedoseyeva E; Lehmann PV; Olson CA; Geysen HM; McMillan M; Sercarz EE
    J Immunol; 1994 Aug; 153(3):938-45. PubMed ID: 7517977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of chronic renal allograft injury by injection of a monoclonal antibody against a donor MHC Ib molecule in a nude rat model.
    Koch M; Broecker V; Heratizadeh A; Doege C; Strehlau J; Mengel M; Nashan B
    Transpl Immunol; 2008 Jul; 19(3-4):187-91. PubMed ID: 18595711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histoincompatibility-associated differences in the phenotypes of murine cardiac allograft infiltrating T cells.
    Carlquist JF; Shelby J; Hammond EH; Greenwood JH; Anderson JL
    Immunology; 1994 May; 82(1):149-53. PubMed ID: 7913913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of allo-recognition. Recognition by in vivo-primed T cells of specific major histocompatibility complex polymorphisms presented as peptides by responder antigen-presenting cells.
    Watschinger B; Gallon L; Carpenter CB; Sayegh MH
    Transplantation; 1994 Feb; 57(4):572-6. PubMed ID: 8116044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allorecognition of isolated, denatured chains of class I and class II major histocompatibility complex molecules. Evidence for an important role for indirect allorecognition in transplantation.
    Dalchau R; Fangmann J; Fabre JW
    Eur J Immunol; 1992 Mar; 22(3):669-77. PubMed ID: 1547813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathways of helper CD4 T cell allorecognition in generating alloantibody and CD8 T cell alloimmunity.
    Taylor AL; Negus SL; Negus M; Bolton EM; Bradley JA; Pettigrew GJ
    Transplantation; 2007 Apr; 83(7):931-7. PubMed ID: 17460565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Humoral immunity in allograft rejection. The role of cytotoxic alloantibody in hyperacute rejection and enhancement of rat cardiac allografts.
    Oluwole SF; Tezuka K; Wasfie T; Stegall MD; Reemtsma K; Hardy MA
    Transplantation; 1989 Nov; 48(5):751-5. PubMed ID: 2815247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mobilization of T lymphocytes following cardiac transplantation. Evidence that CD4-positive cells are required for cytotoxic T lymphocyte activation, inflammatory endothelial development, graft infiltration, and acute allograft rejection.
    Bishop DK; Shelby J; Eichwald EJ
    Transplantation; 1992 Apr; 53(4):849-57. PubMed ID: 1533070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cellular and molecular mechanisms of human cardiac myocyte injury after transplantation.
    Ansari AA; Sundstrom JB; Kanter K; Mayne A; Villinger F; Gravanis MB; Herskowitz A
    J Heart Lung Transplant; 1995; 14(1 Pt 1):102-12. PubMed ID: 7727458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intrathymic immunomodulation in sensitized rat recipients of cardiac allografts: requirements for allorecognition pathways.
    Stadlbauer TH; Schaub M; Magee CC; Kupiec-Weglinski JW; Sayegh MH
    J Heart Lung Transplant; 2000 Jun; 19(6):566-75. PubMed ID: 10867337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune mechanisms in organ allograft rejection. V. Pivotal role of the cytotoxic-suppressor T cell subset in the rejection of heart grafts bearing isolated class I disparities in the inbred rat.
    Lowry RP; Forbes RD; Blackburn JH; Marghesco DM
    Transplantation; 1985 Nov; 40(5):545-50. PubMed ID: 3904091
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased anti-donor major histocompatibility complex class I and increased class II alloantibody response in allograft tolerance in adult rats.
    Cuturi MC; Josien R; Cantarovich D; Bugeon L; Anegon I; Menoret S; Smit H; Douillard P; Soulillou JP
    Eur J Immunol; 1994 Jul; 24(7):1627-31. PubMed ID: 8026523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Donor-specific cellular immunity in rejecting and long-term-surviving class I-disparate rat renal allograft recipients.
    Ruiz P; Fuller J; Sanfilippo F
    Transplantation; 1990 Jan; 49(1):175-83. PubMed ID: 2301009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protection of heart and rejection of lymphocyte allografts from the same donor in recipients of donor-specific transfusions.
    Jaskłowska-Englisz M; Olszewski WL; Maksymowicz M; Ziółkowska A
    Ann Transplant; 1998; 3(1):28-33. PubMed ID: 9869895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterogeneity of CD4+ T cells involved in anti-allo-class I H-2 immune responses. Functional discrimination between the major proliferating cells and helper cells assisting cytotoxic T cell responses.
    Kitagawa S; Sato S; Azuma T; Shimizu J; Hamaoka T; Fujiwara H
    J Immunol; 1991 Apr; 146(8):2513-21. PubMed ID: 1673140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 59.